Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice
Drozd, Daniel R.
Saag, Michael S.
Westfall, Andrew O.
Mathews, William Chris
Cole, Stephen R.
Kitahata, Mari M.
Rosenblatt, LisaNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationDrozd, D. R., M. S. Saag, A. O. Westfall, W. C. Mathews, R. Haubrich, S. L. Boswell, S. R. Cole, et al. 2017. “Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.” Medicine 96 (14): e6275. doi:10.1097/MD.0000000000006275. http://dx.doi.org/10.1097/MD.0000000000006275.
AbstractAbstract We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:33029882
- HMS Scholarly Articles